Morris Matthew Shawn
Director at PRVA; EVP at HealthSpring, Inc.
- Sold, on record
- $78M
- Dollars the filings state
- Form 4 sales
- 30
- Latest Jul 6, 2026
- Form 144 notices
- 4
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- PRVAPrivia Health Group, Inc.Director
- HealthSpring, Inc.EVP
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- PRVA2.4M shares
- HealthSpring, Inc.160,000 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale PRVANo planApr 30, 2024 2024
Sold 11,059 shares at $18.42 ($204k)
Morris Matthew Shawn, Director
No 10b5-1 planSold 13.6% of holdings ($1.5M position)70,101 shares left0.2x usual sizeFollows a Form 144Filing
- 2 Form 4 sale PRVANo planApr 30, 2025 +365 days
Sold 10,309 shares at $23.33 ($241k)
Morris Matthew Shawn, Director
No 10b5-1 planSold 14.7% of holdings ($1.6M position)59,792 shares left0.3x usual sizeFiling
- 3 Form 4 sale PRVARoutineDec 12, 2025 +226 days
Sold 13,647 shares at $25.01 ($341k)
Morris Matthew Shawn, Director
10b5-1 planSold 16.7% of holdings ($2M position)68,188 shares leftFiling
- 4 Form 4 sale PRVARoutineFeb 27, 2026 +77 days
Sold 24,338 shares at $25.00 ($608k)
Morris Matthew Shawn, Director
10b5-1 planSold 26.3% of holdings ($2.3M position)68,188 shares left2.2x usual sizeFiling
- 5 Form 4 sale PRVARoutineMay 4, 2026 +66 days
Sold 18,113 shares at $24.99 ($453k)
Morris Matthew Shawn, Director
10b5-1 planSold 21% of holdings ($2.2M position)68,188 shares left1.3x usual sizeFiling
- 6 Form 4 sale PRVAUnusualJun 29, 2026 +56 days
Sold 151,322 shares at $25.33 ($3.8M)
Morris Matthew Shawn, Director
10b5-1 planSold 66.4% of holdings ($5.8M position)76,651 shares left9.5x usual sizeFiling
- 7 Form 4 sale PRVAUnusualJul 1, 2026 +2 days
Sold 135,498 shares at $26.32 ($3.6M)
Morris Matthew Shawn, Director
10b5-1 planSold 63.9% of holdings ($5.6M position)76,651 shares left7.5x usual sizeFiling
- 8 Form 4 sale PRVAUnusualJul 6, 2026 +5 days
Sold 112,759 shares at $27.29 ($3.1M)
Morris Matthew Shawn, Director
10b5-1 planSold 62.3% of holdings ($4.9M position)68,188 shares left5.3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (34)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 6, 2026 | Jul 7, 2026 | PRVA | Director | Form 4 sale | 112,759 | $3.1M | 62.3% | Unusual | SEC |
| Jul 1, 2026 | Jul 2, 2026 | PRVA | Director | Form 4 sale | 135,498 | $3.6M | 63.9% | Unusual | SEC |
| Jun 29, 2026 | Jun 30, 2026 | PRVA | Director | Form 4 sale | 151,322 | $3.8M | 66.4% | Unusual | SEC |
| May 4, 2026 | May 5, 2026 | PRVA | Director | Form 4 sale | 18,113 | $453k | 21.0% | Routine | SEC |
| Feb 27, 2026 | Mar 2, 2026 | PRVA | Director | Form 4 sale | 24,338 | $608k | 26.3% | Routine | SEC |
| Dec 12, 2025 | Dec 16, 2025 | PRVA | Director | Form 4 sale | 13,647 | $341k | 16.7% | Routine | SEC |
| Apr 30, 2025 | May 2, 2025 | PRVA | Director | Form 4 sale | 10,309 | $241k | 14.7% | No plan | SEC |
| Apr 30, 2024 | May 2, 2024 | PRVA | Director | Form 4 sale | 11,059 | $204k | 13.6% | No plan | SEC |
| Apr 30, 2024 | Apr 30, 2024 | PRVA | Director | Form 144 notice | 11,059 | $204k | Notice | SEC | |
| Jun 13, 2023 | Jun 14, 2023 | PRVA | Chief Executive Officer | Form 4 sale | 335,801 | $9.6M | 76.1% | Unusual | SEC |
| Jun 12, 2023 | Jun 12, 2023 | PRVA | Officer | Form 144 notice | 1.2M | $33M | Notice | SEC | |
| May 2, 2023 | May 3, 2023 | PRVA | Chief Executive Officer | Form 4 sale | 33,279 | $923k | 24.0% | Routine | SEC |
| May 2, 2023 | May 2, 2023 | PRVA | Officer | Form 144 notice | 8,094 | $221k | Notice | SEC | |
| May 1, 2023 | May 1, 2023 | PRVA | Officer, Director | Form 144 notice | 8,000 | $221k | Notice | SEC | |
| Apr 12, 2023 | Apr 13, 2023 | PRVA | Chief Executive Officer | Form 4 sale | 26,056 | $732k | 17.6% | Routine | SEC |
| Apr 4, 2023 | Apr 5, 2023 | PRVA | Chief Executive Officer | Form 4 sale | 7,076 | $199k | 5.5% | Routine | SEC |
| Mar 7, 2023 | Mar 8, 2023 | PRVA | Chief Executive Officer | Form 4 sale | 81,432 | $2.3M | 40.1% | Unusual | SEC |
| Nov 15, 2022 | Nov 17, 2022 | PRVA | Chief Executive Officer | Form 4 sale | 1,200 | $34k | 1.0% | Plan not stated | SEC |
| Nov 4, 2022 | Nov 7, 2022 | PRVA | Chief Executive Officer | Form 4 sale | 31,250 | $929k | 20.4% | Plan not stated | SEC |
| Oct 14, 2022 | Oct 17, 2022 | PRVA | Chief Executive Officer | Form 4 sale | 50,780 | $1.7M | 29.4% | Unusual | SEC |
| Oct 4, 2022 | Oct 5, 2022 | PRVA | Chief Executive Officer | Form 4 sale | 54,722 | $1.9M | 31.0% | Unusual | SEC |
| Sep 22, 2022 | Sep 23, 2022 | PRVA | Chief Executive Officer | Form 4 sale | 11,970 | $431k | 9.0% | Plan not stated | SEC |
| Sep 7, 2022 | Sep 8, 2022 | PRVA | Chief Executive Officer | Form 4 sale | 65,850 | $2.6M | 35.1% | Unusual | SEC |
| Aug 26, 2022 | Aug 29, 2022 | PRVA | Chief Executive Officer | Form 4 sale | 134,911 | $5.5M | 52.6% | Unusual | SEC |
| Aug 16, 2022 | Aug 17, 2022 | PRVA | Chief Executive Officer | Form 4 sale | 136,008 | $4.9M | 52.8% | Unusual | SEC |
| Jul 20, 2022 | Jul 21, 2022 | PRVA | Chief Executive Officer | Form 4 sale | 233,572 | $8M | 65.7% | Unusual | SEC |
| Jul 8, 2022 | Jul 11, 2022 | PRVA | Chief Executive Officer | Form 4 sale | 159,465 | $5.4M | 56.7% | Unusual | SEC |
| Jun 23, 2022 | Jun 24, 2022 | PRVA | Chief Executive Officer | Form 4 sale | 147,377 | $4.3M | 54.8% | Unusual | SEC |
| Nov 23, 2021 | Nov 26, 2021 | PRVA | CHIEF EXECUTIVE OFFICER | Form 4 sale | 339,062 | $9.4M | 73.6% | Unusual | SEC |
| Nov 22, 2021 | Nov 24, 2021 | PRVA | CHIEF EXECUTIVE OFFICER | Form 4 sale | 29,228 | $822k | 19.4% | Plan not stated | SEC |
| Nov 4, 2021 | Nov 8, 2021 | PRVA | Chief Executive Officer | Form 4 sale | 1,200 | $34k | 1.0% | Plan not stated | SEC |
| Mar 17, 2011 | Mar 18, 2011 | HealthSpring, Inc. | EVP | Form 4 sale | 10,091 | $379k | 15.3% | Plan not stated | SEC |
| Mar 11, 2011 | Mar 11, 2011 | HealthSpring, Inc. | EVP | Form 4 sale | 99,909 | $3.8M | 64.1% | Unusual | SEC |
| Feb 24, 2011 | Feb 25, 2011 | HealthSpring, Inc. | EVP | Form 4 sale | 50,000 | $1.9M | 49.7% | Unusual | SEC |